Relapsed large B-cell lymphoma
Clinical trials for Relapsed large B-cell lymphoma explained in plain language.
Never miss a new study
Get alerted when new Relapsed large B-cell lymphoma trials appear
Sign up with your email to follow new studies for Relapsed large B-cell lymphoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug offers hope for lymphoma patients who Can't get transplants
Disease control Recruiting nowThis phase 2 study tests the drug epcoritamab in 30 people with relapsed or refractory large B-cell lymphoma who are not eligible for a stem cell transplant. Epcoritamab is a bispecific antibody that helps the immune system target and kill cancer cells. The main goal is to see ho…
Matched conditions: RELAPSED LARGE B-CELL LYMPHOMA
Phase 2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
New drug combo shows promise for hard-to-treat lymphoma
Disease control Recruiting nowThis study tests a combination of the immunotherapy drug epcoritamab with standard chemotherapy (GDP) in 32 adults whose large B-cell lymphoma has returned or not responded to treatment. The goal is to see if the combo can shrink tumors enough to allow for a stem cell transplant …
Matched conditions: RELAPSED LARGE B-CELL LYMPHOMA
Phase 2 • Sponsor: Dipenkumar Modi • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Engineered immune cells take aim at Tough-to-Treat blood cancers
Disease control Recruiting nowThis trial investigates CRC01, a therapy made from a patient's own immune cells that are genetically modified to recognize and attack cancer cells. It is for adults with large B-cell lymphoma or B-cell acute lymphoblastic leukemia that has returned or not responded to previous tr…
Matched conditions: RELAPSED LARGE B-CELL LYMPHOMA
Phase 1/2 • Sponsor: Curocell Inc. • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Engineered immune cells take on tough lymphoma
Disease control Recruiting nowThis study tests a new treatment called TC011, which uses a patient's own immune cells engineered to find and attack lymphoma cells. It is for adults with large B-cell lymphoma that has come back or not responded to at least two prior treatments. The trial will check safety and h…
Matched conditions: RELAPSED LARGE B-CELL LYMPHOMA
Phase 1/2 • Sponsor: TICAROS Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC